Ovarian Cancer Drugs Market to Hit USD 7.11 Billion by 2032 on Precision Oncology
Key Highlights Global market valued at USD 5.22 billion in 2025. Market projected to reach USD 7.11 billion by 2032. Forecast CAGR stands at 4.5% (2026–2032). Chemotherapy remains the dominant treatment segment. PARP inhibitors represent the fastest-growing therapeutic class. Hospitals continue to account for the largest end-user demand. Precision medicine and companion diagnostics are accelerating … Read more